Business

CHM CDH17 ADVANCES TO DOSE LEVEL 2

CHM CDH17 ADVANCES TO DOSE LEVEL 2

Chimeric Therapeutics LimitedMay 20, 20255
CHM CDH17 ADVANCES TO DOSE LEVEL 2

About this update from Chimeric Therapeutics Limited

Chimeric Therapeutics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Chimeric Therapeutics Limited

More from Chimeric Therapeutics Limited

All Chimeric Therapeutics Limited news →